Vanda Pharmaceuticals P/E Ratio 2011-2026 | VNDA

Annual P/E Ratio Vanda Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-1.62	-13.8	92.9	65.8	26.3	30.6	5.98	56.9	-46.6	-32.1	-9.04	19.2	-19.6	-4.43	-14.1

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
92.9	-46.6	10.4

P/E Ratio of other stocks in the Biotechnology industry

Issuer	P/E Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-0.612	-	2.43 %	$ 254 M	Germany
Grifols, S.A. GRFS	31.7	$ 7.72	1.85 %	$ 6.83 B	Spain
Amphastar Pharmaceuticals AMPH	12.7	$ 19.68	0.92 %	$ 920 M	USA
Amarin Corporation plc AMRN	-150	$ 14.5	0.03 %	$ 6.02 B	Irlanda
GlaxoSmithKline plc GSK	40.5	$ 52.37	1.02 %	$ 173 B	Britain
I-Mab IMAB	-0.236	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	55.7	-	-	$ 40.3 B	USA
Genfit SA GNFT	2.49 K	-	2.54 %	$ 160 B	France
Ascendis Pharma A/S ASND	-19.2	$ 221.59	-0.13 %	$ 5 B	Danmark
Biophytis SA BPTS	-17.6	-	-13.47 %	$ 169 M	France
Autolus Therapeutics plc AUTL	-1.92	$ 1.39	1.46 %	$ 355 M	Britain
Midatech Pharma plc MTP	-14.5	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.57	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	-1.71	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	-5.78	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-4.94	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-0.00095	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-0.0662	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-15.8	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-0.608	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	-4.26	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	38.8	-	-	-	Russia
Heron Therapeutics HRTX	-9.82	$ 0.81	3.74 %	$ 135 M	USA
Avenue Therapeutics ATXI	-0.0465	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	-0.583	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-0.463	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-0.0388	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	-0.203	-	-	$ 7.46 M	Israel
Benitec Biopharma BNTC	-63.2	$ 11.05	0.64 %	$ 455 M	USA
Atreca BCEL	-0.504	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	3.63	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	-392	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	-8.34	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	-0.457	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-0.0138	-	-	$ 3.74 B	USA
Immunovant IMVT	-5.45	$ 24.1	4.85 %	$ 3.65 B	USA
Bellerophon Therapeutics BLPH	-3.96	-	-74.18 %	$ 955 K	USA
Incyte Corporation INCY	15.1	$ 90.36	-0.47 %	$ 17.6 B	USA
InMed Pharmaceuticals INM	-0.216	$ 0.74	-9.75 %	$ 1.81 M	Canada
INmune Bio INMB	-7.04	$ 1.17	-0.43 %	$ 21 M	USA
Checkpoint Therapeutics CKPT	-2.85	-	-	$ 169 M	USA
Clovis Oncology CLVS	-0.873	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	-3.48	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-8.58	-	-	$ 867 M	Germany
Compugen Ltd. CGEN	5.55	$ 2.13	1.91 %	$ 199 M	Israel
Innate Pharma S.A. IPHA	-6.87	$ 1.35	15.38 %	$ 235 M	France
Akero Therapeutics AKRO	-12.9	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	-6.11	$ 4.43	4.6 %	$ 735 M	Canada
Inventiva S.A. IVA	-10.8	$ 6.1	5.5 %	$ 138 M	France
Akouos AKUS	-1.98	-	0.23 %	$ 488 M	USA